Recently, one study using murine BP model demonstrated that anti-IL-17 drugs reduce inflammatory skin lesions and IL-17−/− mice are protected from skin changes, such as erythema, erosion, and crust36. This evidence concerns the gene IL17A and Abnormality of the skin.